Clinical Trial Update: Home basEd faecaL calProtectin Measurements Predicting Adalimumab Induction Destiny [NA]

View source ↗

Summary

A completed KU Leuven study evaluated whether home-based fecal calprotectin measurements can predict the induction outcome of adalimumab in Crohn's disease and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Ulcerative Colitis

Drugs mentioned

• ADALIMUMAB (ADALIMUMAB-AATY)

Snippet

Sponsor: Universitaire Ziekenhuizen KU Leuven | Conditions: Crohn Disease, Colitis, Ulcerative | NA | Status: COMPLETED